LENSAR, Inc. (LNSR) Reports Q4 Loss of $0.78 on Revenues of $8.28M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to LENSAR, Inc. (LNSR) Reports Q4 Loss of $0.78 on Revenues of $8.28M

LENSAR Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

March 10, 2021 7:00 AM EST

Fourth Quarter 2020 Procedure Volumes Consistent with Fourth Quarter 2019 Levels

Cash and Cash Equivalents of $40.6 Million as of December 31, 2020

ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on key strategic and operational initiatives.

2020 was a transformative year for LENSAR, said Nick Curtis, Chief Executive Officer of... More